MM
Mani Mohindru
Chief Executive Officer

Mani Mohindru insider trades: Cardiff Oncology (CRDF) stock buys and sales

Chief Executive Officer, Cardiff Oncology Last trade Jul 14, 2026 29 Form 4 filings
$0
Sold, last 12 months
0 sales
$80K
Bought, last 12 months
2 buys
9
Open-market trades
since 2018
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Mani reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 14, 2026CRDF↑ Buy$50K
Jun 18, 2026CRDF↑ Buy$30K
Dec 4, 2019CARA↓ Sell$81K
Jul 15, 2019CARA↓ Sell$936K
May 29, 2019CARA↓ Sell$53K
Mar 13, 2019CARA↓ Sell$307K
Dec 28, 2018CARA↓ Sell$56K
Nov 15, 2018CARA↓ Sell$297K
Oct 17, 2018CARA↓ Sell$324K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CRDF insiders

Open-market trades in the last 12 months

About Mani Mohindru's insider trades

Mani Mohindru is Chief Executive Officer at Cardiff Oncology (CRDF). Since Oct 17, 2018, Mani has reported 2 open-market purchases worth $80K and 7 sales worth $2.1M on SEC Form 4. In the last 12 months: 2 buys ($80K).

Their filings also include grants and awards (22 filings), option exercises (4 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRDF insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.